Statements of Operations (USD $)	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010
Revenues:
Product sales	$ 8,395	$ 5,150
Sublicense fee and royalty revenue	50,000
Total revenues	58,395	5,150
Cost of revenues:
Product sales	4,354	2,943
Total cost of revenues	4,354	2,943
Gross margin	54,041	2,207
Operating expenses:
Research and development expenses	281,107	433,357
Selling, general and administrative expenses	918,814	638,164
Total operating expenses	1,199,921	1,071,521
Operating loss	(1,145,880)	(1,069,314)
Other income (expense):
Derivative gain	36,468	1,668,336
Interest expense	(211,718)	(93,950)
Other income	7,357	1,240
Net income (loss)	(1,313,773)	506,312
Preferred stock dividend	(16,956)	(4,200)
Net income (loss) applicable to common shareholders	$ (1,330,729)	$ 502,112
Basic net income (loss) per average share available to common shareholders	$ (0.02)	$ 0.01
Diluted net income (loss) per average share available to common shareholders	$ (0.02)	$ 0.01
Weighted average common shares outstanding - basic	65,028,701	55,041,854
Weighted average common shares outstanding - diluted	65,028,701	56,889,076